The performance of companies tied to Sildenafil's legacy presents a challenging investment landscape. While the initial boom generated substantial gains, generic alternatives have significantly impacted https://thebookmarkfree.com/story21730242/copyright-s-flagship-product-and-the-pharmaceutical-sector-a-uncertain-venture